BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23044607)

  • 1. Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystack.
    White RJ; Morrell NW
    Circulation; 2012 Oct; 126(15):1818-20. PubMed ID: 23044607
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance.
    Cogan J; Austin E; Hedges L; Womack B; West J; Loyd J; Hamid R
    Circulation; 2012 Oct; 126(15):1907-16. PubMed ID: 22923426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waiting in anticipation: the genetics of pulmonary arterial hypertension.
    Aldred MA; Morrell NW
    Am J Respir Crit Care Med; 2012 Nov; 186(9):820-1. PubMed ID: 23118082
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Kataoka M; Satoh T; Fukuda K
    Circulation; 2016 Aug; 134(9):e115-6. PubMed ID: 27572882
    [No Abstract]   [Full Text] [Related]  

  • 5. Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    van der Bruggen CE; Happé CM; Goumans MJ; Bogaard HJ; Vonk Noordegraaf A; de Man FS
    Circulation; 2016 Aug; 134(9):e117-8. PubMed ID: 27572883
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution.
    Hamid R; Loyd J
    Eur Respir J; 2012 Jun; 39(6):1292-3. PubMed ID: 22654004
    [No Abstract]   [Full Text] [Related]  

  • 7. Fat and cardiotoxicity in hereditary pulmonary hypertension.
    Tuder RM; Robinson JC; Graham BB
    Am J Respir Crit Care Med; 2014 Feb; 189(3):247-9. PubMed ID: 24484329
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics of pulmonary arterial hypertension.
    Elliott CG
    Clin Chest Med; 2013 Dec; 34(4):651-63. PubMed ID: 24267296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable pulmonary arterial hypertension with elevated pulmonary wedge pressure.
    Digne F; Sablayrolles JL; Montani D; Laperche T; Rousseau J; Guyon P; Stratiev V; Royer T; Attias D
    Circulation; 2012 Aug; 126(9):e124-7. PubMed ID: 22927477
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
    Flynn C; Zheng S; Yan L; Hedges L; Womack B; Fessel J; Cogan J; Austin E; Loyd J; West J; Zhao Z; Hamid R
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):20-7. PubMed ID: 22312021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.
    Roberts KE; Barst RJ; McElroy JJ; Widlitz A; Chada K; Knowles JA; Morse JH
    Chest; 2005 Dec; 128(6 Suppl):618S. PubMed ID: 16373874
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Genetic Diagnosis of Pulmonary Arterial Hypertension: An Increased Complexity.
    Eyries M; Soubrier F
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1003-1004. PubMed ID: 27634583
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatic mutations in pulmonary arterial hypertension: primary or secondary events?
    Austin ED; Hamid R; Ahmad F
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1094-6. PubMed ID: 21041561
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension.
    Rubin LJ
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893872
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics of pulmonary arterial hypertension.
    Austin ED; Loyd JE; Phillips JA
    Semin Respir Crit Care Med; 2009 Aug; 30(4):386-98. PubMed ID: 19634078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Notch1 in Pulmonary Hypertension.
    Babicheva A; Yuan JX
    Circ Res; 2019 Jan; 124(2):176-179. PubMed ID: 30653427
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
    Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genes and pulmonary arterial hypertension.
    Sztrymf B; Yaïci A; Girerd B; Humbert M
    Respiration; 2007; 74(2):123-32. PubMed ID: 17318011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension for clinicians: time to call on genetics?
    Reichenberger F
    Respiration; 2010; 79(4):274-5. PubMed ID: 19996574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.